Nurture Genomics
Cambridge, US · Founded 2022 · Delaware corporation · 1 known investors
Find your way into Nurture Genomics
Nurture Genomics is working to bring population-based genomic screening into routine pediatric care, using genetic sequencing to identify actionable genetic conditions before symptoms appear. It partners with organizations in pediatric genomics to support earlier intervention and more personalized care.
Founders & leadership
Nurture Genomics was founded in 2022 by Robert C Green.
RC
Robert C GreenFounder
SB
Steffanie BristolinStrategic Advisor (Formerly Interim CEO)
DF
David FeinbergExecutive
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.3M disclosed across 1 round · 2022
▶$4.3MraisedSep 2025 · 40 investors · Other Health CareRule 506(b)
▶$4.3MraisedSep 2025 · 40 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steffanie BristolExecutive Officer
- Robert C GreenExecutive Officer, Director
- David FeinbergExecutive Officer
- Offering amount
- $6M
- Amount sold
- $4.3M
- Proceeds to insiders
- $250K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Nurture Genomics do?
- Nurture Genomics is working to bring population-based genomic screening into routine pediatric care, using genetic sequencing to identify actionable genetic conditions before symptoms appear. It partners with organizations in pediatric genomics to support earlier intervention and more personalized care.
- Who founded Nurture Genomics?
- Nurture Genomics was founded by Robert C Green in 2022.
- Who are Nurture Genomics's investors?
- Nurture Genomics's investors include Bantam Group.
- How much funding has Nurture Genomics raised?
- Nurture Genomics has disclosed $4.3M raised across 1 round.
- Where is Nurture Genomics headquartered?
- Nurture Genomics is headquartered in Cambridge, US.